These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Randomised controlled trial of inhaled corticosteroids (fluticasone propionate) in cystic fibrosis. Balfour-Lynn IM; Klein NJ; Dinwiddie R Arch Dis Child; 1997 Aug; 77(2):124-30. PubMed ID: 9301350 [TBL] [Abstract][Full Text] [Related]
10. Randomized, double-blind, placebo-controlled, dose-escalating study of aerosolized interferon gamma-1b in patients with mild to moderate cystic fibrosis lung disease. Moss RB; Mayer-Hamblett N; Wagener J; Daines C; Hale K; Ahrens R; Gibson RL; Anderson P; Retsch-Bogart G; Nasr SZ; Noth I; Waltz D; Zeitlin P; Ramsey B; Starko K Pediatr Pulmonol; 2005 Mar; 39(3):209-18. PubMed ID: 15573395 [TBL] [Abstract][Full Text] [Related]
11. Long-term treatment with oral N-acetylcysteine: affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled trial. Conrad C; Lymp J; Thompson V; Dunn C; Davies Z; Chatfield B; Nichols D; Clancy J; Vender R; Egan ME; Quittell L; Michelson P; Antony V; Spahr J; Rubenstein RC; Moss RB; Herzenberg LA; Goss CH; Tirouvanziam R J Cyst Fibros; 2015 Mar; 14(2):219-27. PubMed ID: 25228446 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of aerosolized tobramycin in patients with cystic fibrosis. Ramsey BW; Dorkin HL; Eisenberg JD; Gibson RL; Harwood IR; Kravitz RM; Schidlow DV; Wilmott RW; Astley SJ; McBurnie MA N Engl J Med; 1993 Jun; 328(24):1740-6. PubMed ID: 8497284 [TBL] [Abstract][Full Text] [Related]
13. Cytokines in neutrophil-dominated airway inflammation in patients with cystic fibrosis. Schuster A; Haarmann A; Wahn V Eur Arch Otorhinolaryngol; 1995; 252 Suppl 1():S59-60. PubMed ID: 7537567 [TBL] [Abstract][Full Text] [Related]
14. Effect of fluticasone propionate on sputum of patients with chronic bronchitis and emphysema. Llewellyn-Jones CG; Harris TA; Stockley RA Am J Respir Crit Care Med; 1996 Feb; 153(2):616-21. PubMed ID: 8564107 [TBL] [Abstract][Full Text] [Related]
15. Effect of clarithromycin on airway obstruction and inflammatory markers in induced sputum in cystic fibrosis: a pilot study. Ordoñez CL; Stulbarg M; Grundland H; Liu JT; Boushey HA Pediatr Pulmonol; 2001 Jul; 32(1):29-37. PubMed ID: 11416873 [TBL] [Abstract][Full Text] [Related]
16. Sputum club cell protein concentration is associated with pulmonary exacerbation in cystic fibrosis. Laguna TA; Williams CB; Brandy KR; Welchlin-Bradford C; Moen CE; Reilly CS; Wendt CH J Cyst Fibros; 2015 May; 14(3):334-40. PubMed ID: 25456770 [TBL] [Abstract][Full Text] [Related]
17. Neutrophil elastase correlates with increased sphingolipid content in cystic fibrosis sputum. Karandashova S; Kummarapurugu A; Zheng S; Kang L; Sun S; Rubin BK; Voynow JA Pediatr Pulmonol; 2018 Jul; 53(7):872-880. PubMed ID: 29624923 [TBL] [Abstract][Full Text] [Related]
18. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. Ramsey BW; Pepe MS; Quan JM; Otto KL; Montgomery AB; Williams-Warren J; Vasiljev-K M; Borowitz D; Bowman CM; Marshall BC; Marshall S; Smith AL N Engl J Med; 1999 Jan; 340(1):23-30. PubMed ID: 9878641 [TBL] [Abstract][Full Text] [Related]
19. Circulating immunoreactive interleukin-6 in cystic fibrosis. Nixon LS; Yung B; Bell SC; Elborn JS; Shale DJ Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1764-9. PubMed ID: 9620903 [TBL] [Abstract][Full Text] [Related]